| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | +14.4% |
| Cost of Revenue | $477.5M | +10.4% |
| Gross Profit | $564.4M | +18.1% |
| R&D Expense | $166.2M | +6.1% |
| SG&A Expense | $137.6M | +11.8% |
| Operating Income | -$51.3M | +48.0% |
| Pre-tax Income | -$12.8M | +83.9% |
| Income Tax | $40K | -98.3% |
| Net Income | -$12.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $362.5M | +153.2% |
| Accounts Receivable | $115.2M | +18.2% |
| Current Assets | $1.25B | +35.1% |
| Total Assets | $2.05B | +37.2% |
| Current Liabilities | $641.7M | +283.8% |
| Total Liabilities | $1.43B | +49.4% |
| Stockholders' Equity | $622.2M | +15.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $143.2M | +11.1% |
| Capital Expenditures | $42.4M | +35.7% |
| Investing Cash Flow | -$266.6M | -2.7% |
| Financing Cash Flow | $342.7M | +262.4% |
| Free Cash Flow | $100.8M | +3.3% |
| +84.4% |
| EPS (Basic) | -$0.17 | +85.0% |
| EPS (Diluted) | -$0.17 | +85.0% |